New insights into the burden and costs of multiple sclerosis in Europe

Por Kobelt, Gisela, Thompson, Alan, Berg, Jenny, Gannedahl, Mia, Eriksson, Jennifer
Publicado no Mult Scler (2017)

Mapping the Kansas City Cardiomyopathy Questionnaire (KCCQ) Onto EQ-5D-3L in Heart Failure Patients: Results for the Japanese and UK Value Sets

Por Hunger, Matthias, Eriksson, Jennifer, Regnier, Stephane A., Mori, Katsuya, Spertus, John A., Cristino, Joaquim
Publicado no MDM Policy Pract (2020)

Simulating the Impact of Improved Cardiovascular Risk Interventions on Clinical and Economic Outcomes in Russia

Por Shum, Kenny, Alperin, Peter, Shalnova, Svetlana, Boytsov, Sergey, Kontsevaya, Anna, Vigdorchik, Alexey, Guetz, Adam, Eriksson, Jennifer, Hughes, David
Publicado em 2014

NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK

Por Cawston, Helene, Bourhis, Francois, Eriksson, Jennifer, Ruffo, Pierfrancesco, D’Agostino, Paolo, Turini, Marco, Schwartzberg, Lee, McGuire, Alistair
Publicado no Drugs Context (2017)

Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal Cancer

Por Eriksson, Jennifer, Amonkar, Mayur, Al-Jassar, Gemma, Lambert, Jeremy, Malmenäs, Mia, Chase, Monica, Sun, Lucy, Kollmar, Linda, Vichnin, Michelle
Publicado no J Clin Med (2019)

Quality of Life and Utility in Patients with Metastatic Soft Tissue and Bone Sarcoma: The Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study

Por Reichardt, Peter, Leahy, Michael, Garcia del Muro, Xavier, Ferrari, Stefano, Martin, Javier, Gelderblom, Hans, Wang, Jingshu, Krishna, Arun, Eriksson, Jennifer, Staddon, Arthur, Blay, Jean-Yves
Publicado em 2012